The 2018 Korean Society of Hypertension guidelines provide customized blood pressure targets and initial drug choices for hypertensive patients with special conditions such as diabetes, chronic kidney disease, and cardiovascular disease.
Provides the 2018 Korean Society of Hypertension guidelines for managing hypertension in special populations such as those with diabetes, CKD, or cardiovascular disease.
Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients' characteristics. Additionally, the target blood pressure or initial drug choice should be customized according to the special conditions of the hypertensive patients. In this part III, we reviewed previous data and presented recommendations for some special populations such as diabetes mellitus, chronic kidney disease, elderly people, and cardio-cerebrovascular disease.
Kim et al. (Thu,) conducted a review in Hypertension in special situations (diabetes, chronic kidney disease, elderly, cardio-cerebrovascular disease). Antihypertensive treatment was evaluated. The 2018 Korean Society of Hypertension guidelines provide customized blood pressure targets and initial drug choices for hypertensive patients with special conditions such as diabetes, chronic kidney disease, and cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: